# China SXT Pharmaceuticals Inc. (SXTC)

Source: https://www.quantisnow.com/company/SXTC
Generated: 2026-11-19T00:47:03.560Z

- Ticker: SXTC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2019
- SEC CIK: 0001723980
- Website: sxtchina.com

## About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of July 31, 2021, its end-customer base includes 70 pharmaceutical companies, 12 chain pharmacies, and 59 hospitals in 10 provinces and municipalities in China, including Jiangsu, Hubei, Shandong, Guangdong, Liaoning, Anhui, Henan, Jiangxi, Heilongjiang, and Hainan. The company was founded in 2005 and is based in Taizhou, China.

## Latest SXTC news and filings

- 2026-10-22 12:00 UTC [China SXT Pharmaceuticals, Inc. Announces Share Consolidation](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-share-consolidation-6754496)
- 2026-10-21 21:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6753857)
- 2026-10-21 12:00 UTC [Public Offering] [China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-termination-of-additional-purchase-right-6752992)
- 2026-10-09 21:30 UTC [Public Offering] [Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)](https://www.quantisnow.com/insight/univest-securities-llc-announces-closing-of-12-million-registered-direct-6743269)
- 2026-10-09 21:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6743147)
- 2026-10-09 13:30 UTC [SEC Form 424B5] [SEC Form 424B5 filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-china-sxt-pharmaceuticals-inc-6742580)
- 2026-10-08 16:07 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6741513)
- 2026-10-08 13:22 UTC [Public Offering] [China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-12-million-registered-direct-offering-6741404)
- 2026-10-08 11:33 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6741063)
- 2026-09-17 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-china-sxt-pharmaceuticals-inc-6718287)
- 2026-08-28 21:00 UTC [Amendment: SEC Form F-3/A filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-f-3a-filed-by-china-sxt-pharmaceuticals-inc-6698629)
- 2026-08-28 21:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6698617)
- 2026-08-05 13:00 UTC [China SXT Pharmaceuticals, Inc. Announces Share Consolidation](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-share-consolidation-6664302)
- 2026-07-24 21:30 UTC [Public Offering] [Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)](https://www.quantisnow.com/insight/univest-securities-llc-announces-closing-of-9-million-registered-direct-6648656)
- 2026-07-24 20:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6648433)
- 2026-07-24 13:00 UTC [SEC Form 424B5] [SEC Form 424B5 filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-china-sxt-pharmaceuticals-inc-6648038)
- 2026-07-23 12:45 UTC [Public Offering] [China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-9-million-registered-direct-offering-6646485)
- 2026-07-07 20:30 UTC [SEC Form F-3 filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-f-3-filed-by-china-sxt-pharmaceuticals-inc-6630244)
- 2026-07-06 20:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6628408)
- 2026-07-01 20:30 UTC [SEC Form 20-F filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-china-sxt-pharmaceuticals-inc-6623217)
- 2026-06-01 21:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6582344)
- 2026-06-01 21:05 UTC [SEC Form 424B5] [SEC Form 424B5 filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-china-sxt-pharmaceuticals-inc-6582338)
- 2026-05-04 21:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6529636)
- 2026-04-27 20:01 UTC [SEC Form 3] [SEC Form 3 filed by new insider Pan Xiaodong Sean](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-pan-xiaodong-sean-6516209)
- 2026-04-27 20:00 UTC [SEC Form 3] [SEC Form 3 filed by new insider Liu Tong Tony](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-liu-tong-tony-6516206)
- 2026-04-27 20:01 UTC [SEC Form 3] [SEC Form 3 filed by new insider Ji Xiaodong](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-ji-xiaodong-6516201)
- 2026-04-27 20:01 UTC [SEC Form 3] [New insider Zhou Feng Felix claimed ownership of 4 units of Class B Ordinary Shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-zhou-feng-felix-claimed-ownership-of-4-units-6516195)
- 2026-04-27 20:01 UTC [SEC Form 3] [SEC Form 3 filed by new insider Chee Yong Lip](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-chee-yong-lip-6516191)
- 2026-04-27 20:00 UTC [SEC Form 3] [SEC Form 3 filed by new insider Simon Lim Sze Beng](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-simon-lim-sze-6516181)
- 2026-04-27 20:00 UTC [SEC Form 3] [SEC Form 3 filed by new insider Zheng Jun](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-zheng-jun-6516172)
- 2026-04-09 13:00 UTC [SEC Form 424B5] [SEC Form 424B5 filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-china-sxt-pharmaceuticals-inc-6494195)
- 2026-04-09 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6494191)
- 2026-03-23 13:00 UTC [China SXT Pharmaceuticals, Inc. Announces Share Re-classification](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-share-re-classification-6464531)
- 2026-01-30 14:00 UTC [China SXT Pharmaceuticals, Inc. Announces Share Consolidation](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-share-consolidation-6367245)
- 2026-01-15 14:00 UTC [CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-strategic-initiative-to-apply-ai-6350364)
- 2026-01-13 22:00 UTC [Public Offering] [Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)](https://www.quantisnow.com/insight/univest-securities-llc-announces-closing-of-10-million-registered-direct-6348373)
- 2026-01-13 21:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-china-sxt-pharmaceuticals-inc-6348023)
- 2026-01-12 15:50 UTC [SEC Form 424B5] [SEC Form 424B5 filed by China SXT Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-china-sxt-pharmaceuticals-inc-6346089)
- 2026-01-09 19:50 UTC [Public Offering] [China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-10-million-registered-direct-offering-6344216)
- 2026-01-08 14:20 UTC [CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT](https://www.quantisnow.com/insight/china-sxt-pharmaceuticals-inc-announces-strategic-ai-insights-initiative-to-6342585)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SXTC
- Earnings history: https://www.quantisnow.com/earnings/SXTC
- Dividend history: https://www.quantisnow.com/dividends/SXTC
- Insider transactions: https://www.quantisnow.com/insiders/SXTC
- Options chain: https://www.quantisnow.com/options/SXTC
- SEC 8-K filings only: https://www.quantisnow.com/company/SXTC/8-k
- RSS and alerts for SXTC: https://www.quantisnow.com/docs/rss-feeds.md
